Serum High-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy in Women With Polycystic Ovary Syndrome: A Prospective, Matched Study
- 14 April 2010
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 61 (6) , 595-601
Abstract
The study evaluated the effect of 5 hormonal regimes on serum levels of high-sensitivity C-reactive protein (hsCRP) and homocysteine (Hcy) in women with polycystic ovary syndrome (PCOS). Women with PCOS received (1) conjugated estrogens and cyproterone acetate (n = 22), (2) 17β-estradiol and cyproterone acetate (n = 17), (3) ethinyl-estradiol and cyproterone acetate (high dose; n = 20), (4) ethinyl-estradiol plus cyproterone acetate (low dose; n = 12), or (5) ethinyl-estradiol plus desogetrel (n = 12). Both hsCRP and Hcy levels were measured at baseline and after 4, 7, and 12 months. The 17β-estradiol/cyproterone acetate regime resulted in significant reduction of both hsCRP and Hcy levels (P < .001). The other 4 regimes only resulted in a reduction of Hcy levels (P < .001). In conclusion, the 17β-estradiol/cyproterone acetate regime had the most favorable effects in women with PCOS regarding serum levels of hsCRP and Hcy.Keywords
This publication has 45 references indexed in Scilit:
- Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?Clinical Endocrinology, 2009
- Evidence of proatherogenic inflammation in polycystic ovary syndromeMetabolism, 2009
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial functionFertility and Sterility, 2009
- Study on Chronic Low-Grade Inflammation and Influential Factors of Polycystic Ovary SyndromeMedical Principles and Practice, 2009
- Vascular Risk in Young Women With Polycystic Ovary and Polycystic Ovary SyndromeObstetrics & Gynecology, 2008
- Metabolic and cardiovascular changes in women with polycystic ovary syndromeInternational Journal of Gynecology & Obstetrics, 2007
- Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndromeGynecological Endocrinology, 2007
- Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndromeGynecological Endocrinology, 2005
- Cardiovascular risk in women with polycystic ovarian syndrome (PCOS)Journal of Clinical Pathology, 2005
- Homocysteine and steroids levels in metformin treated women with polycystic ovary syndromeExperimental and Clinical Endocrinology & Diabetes, 2002